Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening
ACTIVE_NOT_RECRUITING
Status
Conditions
- Incident HPV16, 18, 31, 33, 45, 52 or 58 Infection
Interventions
- BIOLOGICAL: Gardasil 9 2 dose regimen
Sponsor
Karolinska Institutet
Collaborators